Final answer:
The purpose of DHA-IPM 18-001 is to target and inhibit the growth of cancer stem cells in glioblastoma, a type of brain tumor.
Step-by-step explanation:
The purpose of DHA-IPM 18-001 is to serve as a drug development program for treating glioblastoma, a type of brain tumor. It is an investigational therapy designed to specifically target cancer stem cells and inhibit their growth.
This therapy involves the use of an antibody-drug conjugate (ADC) that delivers a cytotoxic drug directly to the cancer cells. The DHA-IPM 18-001 ADC targets a protein called CD199, which is highly expressed on glioblastoma stem cells.
By selectively targeting and killing cancer stem cells, DHA-IPM 18-001 aims to disrupt the growth and progression of glioblastoma, potentially improving patient outcomes.